Every material figure on this page references a numbered source below. We prioritize company and SEC filings, official government and WARN data, and federal immigration data, followed by reputable reporting; anonymous posts are not used as a sole source for any material claim. Confidence labels describe source strength, not certainty for your situation: supported by company, sec, government, or multiple strong sources. (High); credible reporting exists but important details remain incomplete. (Medium); public evidence is incomplete or primarily secondary. (Limited).
U.S. Securities and Exchange Commission (EDGAR) · July 30, 2026 · Accessed October 13, 2026 · primary
Supports: the restructuring programme “includes severance and other employee costs, asset impairments and accelerated asset amortization, and the operating results of certain small non-strategic businesses that we plan to discontinue”, programme costs of $70 million in Q2 2026 and $450 million in H1 2026, against $129 million and $344 million in the same periods of 2025, H1 2026 severance of $370 million within $446 million of pre-tax SG&A programme costs, programme-to-date total costs of $1,199 million pre-tax ($908 million after-tax), including $1,062 million in SG&A, primarily severance of $748 million and asset impairments of $109 million, frozen pension plans referenced in the Corporate segment description
U.S. Securities and Exchange Commission (EDGAR) · April 30, 2026 · Accessed October 13, 2026 · primary
Supports: Q1 2026 programme costs of $377 million pre-tax in SG&A, primarily severance of $337 million, Q1 2025 equivalent of $198 million, primarily severance of $171 million, programme-to-date at Q1 2026 of $1,129 million pre-tax ($855 million after-tax), severance $715 million, asset impairments $101 million
U.S. Securities and Exchange Commission (EDGAR) · February 26, 2026 · Accessed October 13, 2026 · primary
Supports: approximately 67,700 employees worldwide at the end of 2025, with about 88% based in the United States, approximately 8,400 employees held 1.1 million restricted stock awards at the end of 2025, fair value of vested restricted stock of $203 million in 2025, $238 million in 2024 and $220 million in 2023
U.S. Securities and Exchange Commission (EDGAR) · February 27, 2025 · Accessed October 13, 2026 · primary
Supports: approximately 73,500 employees at the end of 2024, with approximately 90% based in the United States, approximately 8,900 employees held 1.3 million restricted stock awards at the end of 2024
U.S. Securities and Exchange Commission (EDGAR) · Accessed October 13, 2026 · primary
Supports: approximately 73,800 employees at 2018-12-31, 73,700 at 2019-12-31, 73,700 at 2020-12-31, 73,700 at 2021-12-31, with 89% US-based, 71,300 at 2022-12-31, with 94% US-based, 72,500 at 2023-12-31, with approximately 93% US-based, technology team of approximately 9,500 employees in 2023
U.S. Securities and Exchange Commission (XBRL financial statement data) · Accessed October 13, 2026 · primary
Supports: annual restructuring charges as tagged in Cigna's own filings: $168M (2021), $22M (2022), $252M (2023), nil (2024)
Modern Healthcare · February 6, 2026 · Accessed October 13, 2026 · secondary
Supports: approximately 2,000 roles eliminated globally by the end of February 2026, fewer than 3% of the global workforce, voluntary separations offered alongside involuntary reductions, company statement about driving greater efficiency and providing transition services
Becker's Payer Issues · February 6, 2026 · Accessed October 13, 2026 · secondary
Supports: approximately 2,000 jobs globally, fewer than 3% of the workforce, spokesperson: “As we drive greater efficiency across our business, we have made the difficult decision to reduce roles in our workforce” and a package including transition services, the cuts followed the February 2026 FTC settlement with Express Scripts over insulin pricing
Becker's Payer Issues · November 13, 2025 · Accessed October 13, 2026 · secondary
Supports: 143 Evernorth Care Group roles in Scottsdale, Arizona, HonorHealth acquiring 11 Evernorth care-delivery facilities, transaction expected to close in January
State of New Jersey · Accessed October 13, 2026 · primary
Supports: Cigna Evernorth Services, Morris Plains NJ, 134 workers, filed 2026-02-01, effective 2026-04-29, Cigna Evernorth Services, Inc., Morris Plains NJ, 62 workers, filed 2025-04-01
State of Arizona · Accessed October 13, 2026 · primary
Supports: Evernorth Care Group, Scottsdale AZ, 143 workers, filed 2025-11-11
LayoffNext · October 13, 2026 · Accessed October 13, 2026 · secondary
Supports: three Cigna and Evernorth filings and 339 workers inside the dataset window, no Connecticut or Missouri filings for Cigna in the window, seven states not covered: AR, MT, NH, ND, OK, WV, WY
U.S. Citizenship and Immigration Services · December 31, 2023 · Accessed October 13, 2026 · primary
Supports: Evernorth Enterprise Services Inc: 3 initial approvals, 279 continuing approvals, 1 continuing denial, Cigna Health and Life Insurance Company: 1 initial approval, 29 continuing approvals, 1 continuing denial, Express Scripts Services Co: 12 continuing approvals, Accredo Health Group Inc: 1 continuing approval, mailing-address states: Missouri and Connecticut
Office of the Federal Register (eCFR) · Accessed October 13, 2026 · primary
Supports: up to 60 consecutive days following cessation of the qualifying employment, once per authorized validity period, discretionary